Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy

Canagliflozin (Cana), an anti-diabetes drug belongs to sodium-glucose cotransporter 2 inhibitor, is gaining interest because of its extra cardiovascular benefits. Ferroptosis is a new mode of cell death, which can promote the occurrence of diabetic cardiomyopathy (DCM). Whether Cana can alleviate DC...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Shuqin, Shi, Hanqiang, Xiong, Lie, Wang, Ping, Shi, Yanbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616119/
https://www.ncbi.nlm.nih.gov/pubmed/36313744
http://dx.doi.org/10.3389/fendo.2022.1011669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616119/
https://www.ncbi.nlm.nih.gov/pubmed/36313744
http://dx.doi.org/10.3389/fendo.2022.1011669

Ejemplares similares